GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Becton, Dickinson and Co (XSWX:BDX) » Definitions » EV-to-EBIT

Becton, Dickinson and Co (XSWX:BDX) EV-to-EBIT : 41.78 (As of May. 05, 2024)


View and export this data going back to 2014. Start your Free Trial

What is Becton, Dickinson and Co EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Becton, Dickinson and Co's Enterprise Value is CHF78,370 Mil. Becton, Dickinson and Co's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 was CHF1,876 Mil. Therefore, Becton, Dickinson and Co's EV-to-EBIT for today is 41.78.

The historical rank and industry rank for Becton, Dickinson and Co's EV-to-EBIT or its related term are showing as below:

XSWX:BDX' s EV-to-EBIT Range Over the Past 10 Years
Min: 12.33   Med: 39.21   Max: 117.11
Current: 39.14

During the past 13 years, the highest EV-to-EBIT of Becton, Dickinson and Co was 117.11. The lowest was 12.33. And the median was 39.21.

XSWX:BDX's EV-to-EBIT is ranked worse than
77.61% of 460 companies
in the Medical Devices & Instruments industry
Industry Median: 20.215 vs XSWX:BDX: 39.14

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Becton, Dickinson and Co's Enterprise Value for the quarter that ended in Mar. 2024 was CHF0 Mil. Becton, Dickinson and Co's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 was CHF1,876 Mil. Becton, Dickinson and Co's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2024 was %.


Becton, Dickinson and Co EV-to-EBIT Historical Data

The historical data trend for Becton, Dickinson and Co's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Becton, Dickinson and Co EV-to-EBIT Chart

Becton, Dickinson and Co Annual Data
Trend Sep14 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23
EV-to-EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only 47.12 85.86 38.64 35.85 42.35

Becton, Dickinson and Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 39.81 41.20 42.35 42.66 40.89

Competitive Comparison of Becton, Dickinson and Co's EV-to-EBIT

For the Medical Instruments & Supplies subindustry, Becton, Dickinson and Co's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Becton, Dickinson and Co's EV-to-EBIT Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Becton, Dickinson and Co's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Becton, Dickinson and Co's EV-to-EBIT falls into.



Becton, Dickinson and Co EV-to-EBIT Calculation

Becton, Dickinson and Co's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=78370.108/1875.733
=41.78

Becton, Dickinson and Co's current Enterprise Value is CHF78,370 Mil.
Becton, Dickinson and Co's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was CHF1,876 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Becton, Dickinson and Co  (XSWX:BDX) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Becton, Dickinson and Co's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2024 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Mar. 2024 ) =EBIT / Enterprise Value (Q: Mar. 2024 )
=1875.733/0
= %

Becton, Dickinson and Co's Enterprise Value for the quarter that ended in Mar. 2024 was CHF0 Mil.
Becton, Dickinson and Co's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was CHF1,876 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Becton, Dickinson and Co EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Becton, Dickinson and Co's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Becton, Dickinson and Co (XSWX:BDX) Business Description

Address
1 Becton Drive, Franklin Lakes, NJ, USA, 07417-1880
Becton, Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures pre-filled devices, diagnostic instruments and reagents, as well as flow cytometry and cell-imaging systems. BD Medical is nearly half of the total business, while BD Life Sciences (26% of estimated 2023 revenue) and BD Interventional (25%) account for the remainder. International revenue accounts for 43% of the company's business.

Becton, Dickinson and Co (XSWX:BDX) Headlines